Accessibility Menu
 
Pharvaris logo

Pharvaris

(NASDAQ) PHVS

Current Price$28.46
Market Cap$1.83B
Since IPO (2021)-2%
5 Year+2%
1 Year+91%
1 Month+7%

Pharvaris Financials at a Glance

Market Cap

$1.83B

Revenue (TTM)

$0.00

Net Income (TTM)

$166.04M

EPS (TTM)

$-3.22

P/E Ratio

-8.88

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$28.46

Volume

8,849

Open

$27.94

Previous Close

$28.46

Daily Range

$27.94 - $28.62

52-Week Range

$11.51 - $29.85

PHVS: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharvaris

Industry

Pharmaceuticals

Employees

114

CEO

Berndt A. E. Modig, MBA, CPA

Headquarters

Leiden, 2333 CH, NL

PHVS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-52%

Return on Capital

-27%

Return on Assets

-49%

Earnings Yield

-11.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.83B

Shares Outstanding

64.06M

Volume

8.85K

Short Interest

0.00%

Avg. Volume

168.66K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$145.69M

EBITDA

$145.59M

Operating Cash Flow

$120.13M

Capital Expenditure

$538.09K

Free Cash Flow

$120.67M

Cash & ST Invst.

$280.73M

Total Debt

$861.47K

Pharvaris Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.83B

N/A

Market Cap/Employee

$16.94M

N/A

Employees

108

N/A

Net Income

$37.14M

+11.0%

EBITDA

$37.21M

+1.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$328.71M

+7.7%

Accounts Receivable

$2.94M

+7.6%

Inventory

$0.00

N/A

Long Term Debt

$441.04K

+2420.2%

Short Term Debt

$137.62K

+38.4%

Return on Assets

-48.99%

N/A

Return on Invested Capital

-27.49%

N/A

Free Cash Flow

$30.69M

+8.6%

Operating Cash Flow

$30.67M

+7.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCRXBioCryst Pharmaceuticals, Inc.
$9.02-3.84%
ZYMEZymeworks Inc.
$25.80-0.54%
IMNMImmunome, Inc.
$21.84-2.72%
NTLAIntellia Therapeutics, Inc.
$13.13-1.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About PHVS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.